Livermore

Definium Therapeutics, Inc.

DFTX
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0001813814

Insider trades, last 90 days

0 buys · 1 sell

  • Sold $721.73K
  • Open-market purchases (P) and sales (S), counted by Form 4 filing.
View insider trades

13F holders, Q2 2026

361

  • +115 vs. Q1 2026
  • Total value $5.35B
View 13F holders

Superinvestors holding DFTX

1

  • At the end of Q2 2026
See all holders

Price chart

Latest insider trades

View all: Latest insider trades

Open-market purchases and sales by DFTX insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 4, 20269:30 PM ETSep 3, 2026Barrow RobertChief Executive OfficerSSaleCommon Shares−19.02K$37.94−$721.73K1.49M−1.3%SEC10b5-1
Jun 26, 2026Jun 25, 2026Sullivan MarkChief Legal OfficerSSaleCommon Shares−13.01K$45.03−$585.75K320.57K−3.9%SEC10b5-1
Jun 26, 2026Jun 25, 2026Karlin DanChief Medical OfficerSSaleCommon Shares−10.04K$45.03−$451.88K503.28K−2.0%SEC10b5-1
Jun 26, 2026Jun 25, 2026Roberts BrandiChief Financial OfficerSSaleCommon Shares−3.01K$45.03−$135.68K209.49K−1.4%SEC10b5-1
Jun 26, 2026Jun 25, 2026Barrow RobertChief Executive OfficerSSaleCommon Shares−29.21K$45.03−$1.32M1.1M−2.6%SEC10b5-1

Top 5 13F holders, Q2 2026

View all: Top 5 13F holders, Q2 2026

The largest institutional positions in DFTX at the end of Q2 2026.

Institutions holding DFTX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.11,232,834$528.39M0.01%+2,752,604+32.5%Added
Avoro Capital Advisors LLC7,188,888$338.17M3.04%+2,188,888+43.8%Added
DRIEHAUS CAPITAL MANAGEMENT LLC6,845,276$322M1.87%+933,387+15.8%Added
Jupiter Topco LLC5,615,645$264M0.11%+5,615,645New
Capital World Investors5,367,723$252.5M0.03%+5,367,723New